Supplemental studies in progress propose that ARV-825 may also be effective in enhancing the response to estrogen deprivation (aromatase inhibition), another ingredient of standard of care in ER+ breast cancer. - "Our study disclosed the vital role on the KLF16/MYC regulatory axis in modulating tumor growth and chemotherapy sensitivity in https://williams999jvf3.wiki-jp.com/user